Abstract

The HAS issued this opinion in response to the referral from the Director General of Health on 20/04/2021 relating to the possibility of carrying out a vaccination schedule with two mRNA vaccines of different specialties in exceptional situations.

  • Recommendation
  • Europe
  • France
  • mRNA vaccines
  • COVID-19